These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12386337)

  • 1. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.
    Ma J; Wollmann R; Lindquist S
    Science; 2002 Nov; 298(5599):1781-5. PubMed ID: 12386337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol.
    Ma J; Lindquist S
    Science; 2002 Nov; 298(5599):1785-8. PubMed ID: 12386336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic prion protein toxicity is independent of cellular prion protein expression and prion propagation.
    Norstrom EM; Ciaccio MF; Rassbach B; Wollmann R; Mastrianni JA
    J Virol; 2007 Mar; 81(6):2831-7. PubMed ID: 17182694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations.
    Fioriti L; Dossena S; Stewart LR; Stewart RS; Harris DA; Forloni G; Chiesa R
    J Biol Chem; 2005 Mar; 280(12):11320-8. PubMed ID: 15632159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of neurotoxicity of pathological prion protein.
    Castilla J; Hetz C; Soto C
    Curr Mol Med; 2004 Jun; 4(4):397-403. PubMed ID: 15354870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation.
    Ma J; Lindquist S
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14955-60. PubMed ID: 11742063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion proteins meet protein quality control.
    Dimcheff DE; Portis JL; Caughey B
    Trends Cell Biol; 2003 Jul; 13(7):337-40. PubMed ID: 12837603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
    Mishra RS; Bose S; Gu Y; Li R; Singh N
    J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion diseases: what is the neurotoxic molecule?
    Chiesa R; Harris DA
    Neurobiol Dis; 2001 Oct; 8(5):743-63. PubMed ID: 11592845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transmembrane form of the prion protein in neurodegenerative disease.
    Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
    Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
    Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
    Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain and other cytosolic proteases can contribute to the degradation of retro-translocated prion protein in the cytosol.
    Wang X; Wang F; Sy MS; Ma J
    J Biol Chem; 2005 Jan; 280(1):317-25. PubMed ID: 15525638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein.
    Yedidia Y; Horonchik L; Tzaban S; Yanai A; Taraboulos A
    EMBO J; 2001 Oct; 20(19):5383-91. PubMed ID: 11574470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons.
    Roucou X; Guo Q; Zhang Y; Goodyer CG; LeBlanc AC
    J Biol Chem; 2003 Oct; 278(42):40877-81. PubMed ID: 12917444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
    Mays CE; van der Merwe J; Kim C; Haldiman T; McKenzie D; Safar JG; Westaway D
    J Virol; 2015 Dec; 89(24):12418-26. PubMed ID: 26423957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.
    Kristiansen M; Messenger MJ; Klöhn PC; Brandner S; Wadsworth JD; Collinge J; Tabrizi SJ
    J Biol Chem; 2005 Nov; 280(46):38851-61. PubMed ID: 16157591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transgenic model of a familial prion disease.
    Harris DA; Chiesa R; Drisaldi B; Quaglio E; Migheli A; Piccardo P; Ghetti B
    Arch Virol Suppl; 2000; (16):103-12. PubMed ID: 11214912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction.
    Wang H; Tian C; Fan XY; Chen LN; Lv Y; Sun J; Zhao YJ; Zhang LB; Wang J; Shi Q; Gao C; Chen C; Shao QX; Dong XP
    Int J Biochem Cell Biol; 2015 May; 62():24-35. PubMed ID: 25724737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.